Denmark removes J&J from vaccination program over clot fears

Denmark removes J&J from vaccination program over clot fears


COPENHAGEN, Denmark (AP) — Denmark on Monday removed the single-dose Johnson & Johnson COVID-19 shot from its vaccination program to investigate reports of rare but potentially dangerous blood clots.

Denmark, which has been very cautious with all vaccines, has already taken the AstraZeneca shot out of its vaccination program for the same reason. Both the J&J and AstraZeneca shots are made with similar technology.

The Danish Health Authority said in a statement that it “has concluded that the benefits of using the COVID-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect.”

It added that the European Medicines Agency has concluded that "there is a possible link between rare but severe cases of blood clots (VITT) and the COVID-19 vaccine from Johnson & Johnson.”

“As the COVID-19 epidemic in Denmark is currently under control, and the vaccination rollout is progressing satisfactorily with other available vaccines, the Danish Health Authority has decided to continue the national vaccination campaign without the COVID-19 vaccine from Johnson & Johnson.”

Helene Probst, deputy director general at the Danish Health Authority, noted Monday's decision means that Denmark’s vaccination calendar will be pushed back up to four weeks.

The decision was made at a meeting Monday in parliament between Health Minister Magnus Heunicke and lawmakers from the different parties.

The vaccines made by Pfizer-BioNTech and Moderna represent the bulk of the jabs given in the Scandinavian country of nearly 6 million people. More more than 1.2 million residents have either received the first or the two shots, according to official figures.

The J&J vaccine hadn't been in use in Denmark, but there had been plans to administer the...

Full Article